Abstract:The use of existing mouse models in cancer research is of utmost importance as they aim to explore the casual link between candidate cancer genes and carcinogenesis as well as to provide models to develop and test new therapies. However, faster progress in translating mouse cancer model research into the clinic has been hampered due to the limitations of these models to better reflect the complexities of human tumors. Traditionally, immunocompetent and immunodeficient mice with syngeneic and xenografted tumors transplanted subcutaneously or orthotopically have been used. These models are still being widely employed for many different types of studies, in part due to their widespread availability and low cost. Other types of mouse models used in cancer research comprise transgenic mice in which oncogenes can be constitutively or conditionally expressed and tumor-suppressor genes silenced using conventional methods, such as retroviral infection, microinjection of DNA constructs, and the so-called "gene-targeted transgene" approach. These traditional transgenic models have been very important in studies of carcinogenesis and tumor pathogenesis, as well as in studies evaluating the development of resistance to therapy. Recently, the clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing approach has revolutionized the field of mouse cancer models and has had a profound and rapid impact on the development of more effective systems to study human cancers. The CRISPR/Cas9-based transgenic models have the capacity to engineer a wide spectrum of mutations found in human cancers and provide solutions to problems that were previously unsolvable. Recently, humanized mouse xenograft models that accept patient-derived xenografts and CD34+ cells were developed to better mimic tumor heterogeneity, the tumor microenvironment, and cross-talk between the tumor and stromal/immune cells. These features make them extremely valuable models for the evaluation of investigational cancer therapies, specifically new immunotherapies. Taken together, improvements in both the CRISPR/Cas9 system producing more valid mouse models and in the humanized mouse xenograft models resembling complex interactions between the tumor and its environment might represent one of the successful pathways to precise individualized cancer therapy, leading to improved cancer patient survival and quality of life.

Experimental mouse models for translational human cancer research

Transgenic Mouse Models in Cancer Research

Humanized Rodent Models for Cancer Research

Patient-derived Human Tumour Tissue Xenografts in Immunodeficient Mice: a Systematic Review

Recent advances in the development of transplanted colorectal cancer mouse models

Mouse Tumor Models for Advanced Cancer Immunotherapy

Humanized mouse models: A valuable platform for preclinical evaluation of human cancer

Translation Potential and Challenges of In Vitro and Murine Models in Cancer Clinic

Advances in Prostate Cancer Research Models: from Transgenic Mice to Tumor Xenografting Models

Human tumor xenografts in mouse as a model for evaluating therapeutic efficacy of monoclonal antibodies or antibody-drug conjugate targeting receptor tyrosine kinases.

Mouse Models of Thyroid Cancer: Bridging Pathogenesis and Novel Therapeutics.

Animal models for modeling pancreatic cancer and novel drug discovery

Research Status of Mouse Models for Non-Small-Cell Lung Cancer (NSCLC) and Antitumor Therapy of Traditional Chinese Medicine (TCM) in Mouse Models

Trials, Tribulations, and Trends in Tumor Modeling in Mice

Research progress in experimental animal models of breast cancer

Research progress in the establishment of pancreatic cancer models and preclinical applications

Development of humanized mouse with patient‐derived xenografts for cancer immunotherapy studies: A comprehensive review

Mouse models of breast cancer in preclinical research

If you give a mouse a mutation: comparing the therapeutic utility of renowned mouse models of human cancers

Mouse Models for Human Head and Neck Squamous Cell Carcinomas

Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice